Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Condition: Relapsing-remitting Multiple Sclerosis (RRMS) Intervention: Device: BeCare application Sponsor: Icahn School of Medicine at Mount Sinai Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials
Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab
Condition: Multiple Sclerosis Intervention: Drug: Natalizumab Sponsor: Multiple Sclerosis Center of Northeastern New York Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2021 Category: Research Source Type: clinical trials